QA1.791 Billable Code FY2027 Status: Active

QA1.791: Familial cancer syndrome with pathogenic BRCA2 mutation

Familial cancer syndrome with pathogenic BRCA2 mutation

Effective Date: 2026-10-01
Dataset: ICD-10-CM FY2027
Source: Centers for Disease Control and Prevention (CDC)
Last Verified: 2026-10-01
✔

Quick Clinical & Billing Summary

What is ICD-10-CM code QA1.791? QA1.791 represents Familial cancer syndrome with pathogenic BRCA2 mutation. Under official CDC guidelines, this code is billable and specific for claim submission.

Current release: FY2027 (Effective October 1, 2026). Sourced directly from CDC NCHS files.

Code Hierarchy & Classification

⌊ QA1.791: Familial cancer syndrome with pathogenic BRCA2 mutation (Current Code)

Clinical Guidance & Documentation Standards

Clinical documentation should substantiate the medical necessity of this diagnosis, including laterality, anatomical site specificity, and clinical severity.

Associated Procedures & Medicare RVU Reimbursement

Open RVU Calculator →

Typical outpatient and office evaluation procedures frequently billed alongside diagnosis QA1.791:

CPT/HCPCS Description Work RVU Non-Facility Fee Facility Fee
99213 Office/outpatient visit, established patient, 20-29 minutes (Low MDM) 1.30 $91.69 $66.79
99214 Office/outpatient visit, established patient, 30-39 minutes (Moderate MDM) 1.92 $133.61 $100.21
96372 Therapeutic, prophylactic, or diagnostic injection (subcutaneous/intramuscular) 0.17 $18.34 $12.44
Based on official CMS 2026 Physician Fee Schedule conversion factor ($32.7476). Payments vary by locality GPCI.

CPT Modifier & Billing Rules

Modifier 25 Significant E/M

Append when a significant, separately identifiable evaluation and management service is provided on the same calendar day as a minor surgical procedure or injection.

Modifier 59 Distinct Service

Identifies procedures or services not normally reported together but distinct under the clinical circumstances. Use CMS X-modifiers (XE, XS, XP, XU) where required by Medicare.

Check NCCI Procedure to Procedure (PTP) unbundling rules in NCCI Checker →

Frequently Asked Questions about QA1.791

Is QA1.791 a billable ICD-10 code?

Yes, QA1.791 is a valid, billable and specific ICD-10-CM code. It can be reported as a primary or secondary diagnosis on medical claims.

What is the ICD-10 code for Familial cancer syndrome with pathogenic BRCA2 mutation?

The primary ICD-10-CM code for Familial cancer syndrome with pathogenic BRCA2 mutation is QA1.791.

What is the effective date of the current QA1.791 code?

The code is active for fiscal year FY2027, effective starting 2026-10-01.

AAPC CPC Exam Prep

Preparing for the Certified Professional Coder Exam?

Practice ICD-10-CM code identification, sequencing rules, and guideline application with the full CPC Exam Blueprint course.

Take Free Practice Exam →
Official Provenance: Sourced from CDC / NCHS FY2027 ICD-10-CM files. Report a Data Error
Verified: 2026-10-01